1. In Vivo
  2. >>Growth

Providing A Better Last Mile Experience For Medtech And Patients

Cisco’s Digital Front Door Opens Onto A World Where Patient Engagement Meets Consumerism

 
• By Ashley Yeo

Every part of health care today needs connectivity, says Cisco’s Troy Yoder. He explains the unique role the company’s technology plays in ensuring patients get the best care the medtech industry can offer.

Touch the future,Interface technology, the future of user experience.
• Source: Shutterstock

Troy Yoder and colleagues at Cisco have been fielding the same questions from the health care industry for some time now. “Aren’t you routers, wireless and networking?” they ask. For Cisco, the Annual Conference of the Healthcare Information and Management Systems Society (HIMSS22) in Florida was a good opportunity to walk people through the connectivity journey and explain the increasingly significant role that Cisco plays as health care delivery continues to transform.

Cisco is not a health care company; however, it does have an Industry Solutions Group focused on solution development for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Growth

More from In Vivo

Wide Of The Mark: ‘The Worst EU Medtech Predictions Have Not Come True’

 
• By Ashley Yeo

Jana Grieb, European regulatory and market access legal expert at McDermott Will & Emery, explains why the healthtech and pharma industries are warming to the new EU health commissioner as he faces calls to make the MDR more “user friendly.”

This Belgian Biotech’s Drug Cocktail Could Help Reverse Muscle Aging

 
• By Jo Shorthouse

While big pharma pours billions into creating new anti-aging molecules, a Belgian startup has taken a different path: combining existing safe drugs with AI precision. The early results suggest it might be onto something revolutionary.

Rising Leaders 2025: Doxie Jordan, From UNC Graduate To Global Market Strategist

 
• By Jo Shorthouse

Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy